Cargando…
HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF‐related AMPA receptor activation
We previously showed a hydroxamic acid‐based histone deacetylase inhibitor (HDACi), compound 13, provides neuroprotection against chronic cerebral hypoperfusion (CCH) both in vitro under oxygen‐glucose deprivation (OGD) conditions and in vivo under bilateral common carotid artery occlusion (BCCAO) c...
Autores principales: | Fang, Yao‐Ching, Hsieh, Jia‐Yu, Vidyanti, Amelia Nur, Yang, Chih‐Hao, Jan, Jing‐Shiun, Chang, Kang‐Wei, Hu, Chaur‐Jong, Tu, Yong‐Kwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335662/ https://www.ncbi.nlm.nih.gov/pubmed/34216182 http://dx.doi.org/10.1111/jcmm.16770 |
Ejemplares similares
-
Role of HMGB1 in an Animal Model of Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020) -
HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen‐glucose deprivation injuries via H3K14 and H4K5 acetylation‐mediated BDNF expression
por: Fang, Yao‐Ching, et al.
Publicado: (2020) -
Obesity Is Less Frequently Associated with Cognitive Impairment in Elderly Individuals: A Cross-Sectional Study in Yogyakarta, Indonesia
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020) -
HDACIs and the inhibition of invasive potential
por: Dent, Paul
Publicado: (2013) -
Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells
por: Gnedina, Olga O., et al.
Publicado: (2023)